Allakos Inc. (ALLK) Covered Calls

Allakos Inc. operates as a clinical stage biopharmaceutical company. The company is developing antolimab (AK002) for the treatment of eosinophilic gastritis and eosinophilic gastroenteritis, chronic urticaria, indolent systemic mastocytosis, and severe allergic conjunctivitis. Allakos Inc. was founded in 2012 and is headquartered in Redwood City, California.

You can sell covered calls on Allakos Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ALLK (prices last updated Mon 2:45 PM ET):

Allakos Inc. (ALLK) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.21 +0.05 1.20 1.21 544K - 0.1
Covered Calls For Allakos Inc. (ALLK)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
May 17 1 0.15 1.06 -5.7% -173.4%
Jun 21 1 0.00 1.21 -17.4% -135.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial